News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER launches new funding opportunity for pathobiology research
NIH invites investigators to apply for a new research opportunity, which funds pathobiology studies. Applicants can request use of data and biosamples from RECOVER observational studies and, for the first time, RECOVER clinical trials.
Announcement
53 Results
53 Results
NIH hosts January 10 webinar to discuss RECOVER-TLC’s progress
NIH leaders will provide updates and answer questions about RECOVER’s latest efforts to identify safe and effective treatments for Long COVID.
Announcement
Reviewing RECOVER’s impact in 2024
In 2024, RECOVER continued to advance scientific understanding of Long COVID through observational studies, clinical trials, and community engagement.
Feature
NIH directors highlight RECOVER’s progress and impact
Editorial by NIH leaders shares how RECOVER has worked and will continue working to ease the suffering of those living with Long COVID.
Announcement
NIH adds funds to Long COVID research, advances work on new clinical trials
The $662 million in funds received in 2024 will ensure that researchers can continue making progress toward understanding, diagnosing, preventing, and treating Long COVID through 2029.
News Release
Insights from RECOVER’s pediatric study can inform future clinical trials
Findings from RECOVER’s pediatric observational study are an important first step toward including children in Long COVID clinical trials.
Feature
First webinar of Long COVID treatment initiative highlights early progress
On November 21, NIAID and FNIH launched its first in a series of online webinars highlighting recent progress in the new Researching COVID to Enhance Recovery - Treating Long COVID (RECOVER-TLC) program.
News Release
NIH to share RECOVER-TLC updates during November 21 webinar
NIH leaders will discuss the current status of RECOVER-TLC, share information about potential Long COVID treatments to be tested in RECOVER-TLC clinical trials, and answer questions from the public.
Announcement
NIH invites public participation to inform future Long COVID clinical trials
RECOVER-TLC invites the Long COVID community to submit ideas for potential Long COVID treatments and biomarkers, volunteers for working groups, and provide feedback on the next phase of Long COVID clinical trials.
Feature